Vamorolone, formerly known as VBP-15, is an anti-inflammatory compound used in the treatment of muscular dystrophy. Vamorolone is hoped to retain the beneficial anti-inflammatory and muscle strengthening aspects of corticosteroids, while decreasing or eliminating many of the undesirable side effects (bone fragility, stunted growth, insulin resistance). References: Damsker JM, Conklin LS, Sadri S, Dillingham BC, Panchapakesan K, Heier CR, McCall JM, Sandler AD. VBP15, a novel dissociative steroid compound, reduces NFκB-induced expression of inflammatory cytokines in vitro and symptoms of murine trinitrobenzene sulfonic acid-induced colitis. Inflamm Res. 2016 Sep;65(9):737-43. doi: 10.1007/s00011-016-0956-8. Epub 2016 Jun 3. PubMed PMID: 27261270.

纯度：≥98%

CAS：13209-41-1